SCC
BIOS

Spring Creek Capital’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Spring Creek Capital’s Portfolio BIOS Stock Details BIOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-500,000
Closed -$4.94M – 362
2022
Q1 		$4.94M Buy
+500,000
New +$4.93M 0.2% 82

Other funds holding BIOS

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Spring Creek Capital's BIOS Position: Q2 2022 in Review

Spring Creek Capital sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q2 2022, closing a stake of 500,000 shares — an estimated $4.94M sold.

Spring Creek Capital first reported a position in BIOS in Q1 2022 and held it in 1 quarter. The position peaked at $4.94M in Q1 2022. 65 funds tracked by Wall St. Rank hold BIOS as of Q2 2022.

  • Spring Creek Capital reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Spring Creek Capital sold 500,000 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q2 2022, an estimated $4.94M.
  • Spring Creek Capital first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Spring Creek Capital's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $4.94M in Q1 2022.
  • 65 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q2 2022.

Based on Spring Creek Capital's 13F filing for Q2 2022.